Surprising study suggests urbanization might reduce global infectious disease risk

Ar­riVent Bio­phar­ma, a Penn­syl­va­nia drug­mak­er de­vel­op­ing a Chi­na-ap­proved can­cer treat­ment for the US and oth­er ge­o­gra­phies, plans to raise net pro­ceeds of about $135 mil­lion

Novo Nordisk’s Rybelsus is an oral semaglutide, approved for treating type 2 diabetes. Image credit: JHVEPhoto / Shutterstock. Novo Nordisk plans to file a label

Galera Ther­a­peu­tics is chop­ping 70% of its staff in the wake of a sting­ing FDA re­jec­tion for its ex­per­i­men­tal treat­ment for a ra­dio­ther­a­py com­pli­ca­tion that